Drug delivery device

Information

  • Patent Grant
  • D1055274
  • Patent Number
    D1,055,274
  • Date Filed
    Tuesday, April 26, 2022
    3 years ago
  • Date Issued
    Tuesday, December 24, 2024
    11 months ago
  • Inventors
  • Original Assignees
    • Avaxzipen Limited
  • Examiners
    • Vujcic; Natasha
    • Ford; Gilbert B
    Agents
    • Bochner PLLC
    • Bochner; Andrew
    • Kleinertz; Eric
  • US Classifications
    Field of Search
    • US
    • D24 112-114
    • D24 108
    • D24 133
    • D24 127-130
    • D24 186
    • D24 157
    • CPC
    • A61M5/31596
    • A61M2005/1787
    • A61M2005/31508
    • A61M5/31511
    • A61M2005/3121
    • A61M2005/31598
    • A61M2005/3123
  • International Classifications
    • 2402
    • Term of Grant
      15Years
Abstract
Description


FIG. 1 is a front left perspective view of a drug delivery device;



FIG. 2 is a front right perspective view thereof;



FIG. 3 is a front perspective view thereof;



FIG. 4 is a front left perspective view thereof;



FIG. 5 is a front right perspective view thereof;



FIG. 6 is a front perspective view thereof;



FIG. 7 is a front left perspective view thereof;



FIG. 8 is a front right perspective view thereof;



FIG. 9 is a front perspective view thereof;



FIG. 10 is a front left perspective view thereof;



FIG. 11 is a front right perspective view thereof; and,



FIG. 12 is a front perspective view thereof.


The broken lines in the drawings illustrate portions of the drug delivery device and form no part of the claimed design.


Claims
  • The ornamental design for a drug delivery device, as shown and described.
US Referenced Citations (29)
Number Name Date Kind
D428650 Bellhouse et al. Jul 2000 S
D479748 Tyce Sep 2003 S
D481120 Hawley Oct 2003 S
D548336 Galbraith Aug 2007 S
D555609 Galbraith Nov 2007 S
D567939 Mattigka Apr 2008 S
D619244 Van der Stappen Jul 2010 S
D676547 Quinn et al. Feb 2013 S
D705924 Hunter May 2014 S
D705925 Murray May 2014 S
D749719 Sanders et al. Feb 2016 S
D770611 Saussaye et al. Nov 2016 S
D776261 Jones et al. Jan 2017 S
D786423 Jones et al. May 2017 S
D790687 Jones et al. Jun 2017 S
D792578 Jones et al. Jul 2017 S
D800898 Sanders et al. Oct 2017 S
D808010 Denzer Jan 2018 S
D862690 Jansen Oct 2019 S
D878563 Clawson et al. Mar 2020 S
D886281 Boyaval et al. Jun 2020 S
D888942 Cannamela et al. Jun 2020 S
D890918 Fritz et al. Jul 2020 S
D915584 Eisenkrein et al. Apr 2021 S
D926967 Rogge et al. Aug 2021 S
D926973 Andersen et al. Aug 2021 S
D982744 Ryan Apr 2023 S
D994120 Li Aug 2023 S
20180028798 Conlon et al. Feb 2018 A1
Foreign Referenced Citations (2)
Number Date Country
6056759 Mar 2019 GB
357381-001 May 2023 IN
Non-Patent Literature Citations (3)
Entry
AVaxziPen needle-free vaccine, aVaxziPen, European Pharmaceutical Manufacturer, [Post date: Apr. 3, 2023], [Site seen: May 6, 2024], Seen aT URL: https://pharmaceuticalmanufacturer.media/pharma-manufacturing-news/drug-delivery-news/avaxzipen-announces-positive-data-on-novel-needle-free-%E2%80%A61/4 (Year: 2023).
Whisperject autoinjector, Glatiramer Acetate Injection, [Post date: unknown], [Site seen: May 6, 2024], Seen at URL: https://www.glatirameracetatehcp.com/en/injection-support (Year: 2024).
Kutepatil, O., “Enisi Pharma form an R&D collaboration with Public Health England”, Oct. 2, 2018, news release, retrieved Aug. 24, 2022 from http://exsoft.org/enesi-pharma-forms-rd-public-health-england/ (Year: 2018).
Divisions (1)
Number Date Country
Parent 35510287 Mar 2020 US
Child 29836339 US